ArticlePathology oncology research : POR2012

A novel insulin sensitizer drug candidate-BGP-15-can prevent metabolic side effects of atypical antipsychotics.

Zsuzsanna Literati-Nagy et al.PubMed ↗Publisher ↗

No numbers read from the abstract.